via investorplace.com
University of Leicester researcher in potential medical breakthrough
“This new drug could be a game changer for future treatment of asthma” – Professor Chris Brightling, NIHR Senior Research Fellow at the University of Leicester
The first new asthma pill for nearly 20 years has the power to significantly reduce the severity of the condition, a study led by the University of Leicester has found.
The research was funded by Novartis Pharmaceuticals, National Institute for Health Research (NIHR) and the EU (AirPROM), and is described by the lead researcher as “a game changer for future treatment of asthma.”
Three people die every day because of asthma attacks and research shows that two thirds of asthma deaths are preventable, according to Asthma UK.
Fevipiprant (QAW039) significantly decreased the symptoms of asthma, improved lung function, reduced inflammation and repaired the lining of airways.
The drug is currently being evaluated in late stage clinical trials for efficacy in patients with severe asthma, according to ClinTrials.gov.
A total of 61 people took part in the research. One group was given 225mg of the drug twice a day for 12 weeks and the other participants were assigned to a placebo group. Fevipiprant and the placebo were added to the medications the participants were already taking.
The study was designed primarily to examine the effects on inflammation in the airway by measuring the sputum eosinophil count.
The sputum eosinophil is an inflammation measurement of a white blood cell that increases in asthma and is used to assess the severity of this condition.
People who do not have asthma have a percentage of less than one and those with moderate-to-severe asthma typically have a reading of about five per cent.
The rate in people with moderate-to-severe asthma taking the medication was reduced from an average of 5.4 percent to 1.1 percent over 12 weeks, according to the study published today in the prestigious The Lancet Respiratory Medicine journal.
Professor Christopher Brightling, who is a NIHR Senior Research Fellow and Clinical Professor in Respiratory Medicine at the University of Leicester, led the study at the NIHR Respiratory Biomedical Research Unit, which is based at the Glenfield Hospital in Leicester.
Professor Brightling said: “A unique feature of this study was how it included measurements of symptoms, lung function using breathing tests, sampling of the airway wall and CT scans of the chest to give a complete picture of how the new drug works.
“Most treatments might improve some of these features of disease, but with Fevipiprant improvements were seen with all of the types of tests.
“We already know that using treatments to target eosinophilic airway inflammation can substantially reduce asthma attacks.
“This new treatment, Fevipiprant, could likewise help to stop preventable asthma attacks, reduce hospital admissions and improve day-to-day symptoms- making it a ‘game changer’ for future treatment.”
Gaye Stokes from Grantham in Lincolnshire has had severe asthma for 16 years. She took part in the trial and was part of the Fevipiprant group.
The 54-year-old said: “I knew straight away that I had been given the drug. I felt like a completely different person. I had more get up and go, I was less wheezy and for the first time in years I felt really, really well.
“For me, it felt like a complete wonder drug and I can’t wait for it to be available because I really think it could make a huge difference to me.”
After the 12 week trial and Gaye stopped receiving the drug, she said her health started to “go downhill again very quickly”.
Professor Brightling added that the latest advance underpinned the work of the Leicester Precision Medicine Institute, a Centre of Excellence that coalesces and aligns the research missions of the University of Leicester and the NHS in Leicester.
Future treatment of human disease will increasingly move from a ‘one size fits all’ approach to one of tailoring the treatment to the individual patient.
Asthma is a long-term condition that affects the airways. When a person with asthma comes into contact with something that irritates their sensitive airways it causes the body to react in several ways which can include wheezing, coughing and can make breathing more difficult.
The NIHR Leicester Respiratory Biomedical Research Unit – a partnership between the University of Leicester and Leicester’s Hospitals – focuses on promoting the development of new and effective therapies for the treatment of respiratory diseases including severe asthma and chronic obstructive pulmonary disease (COPD).
Learn more: Asthma pill could reduce symptoms in severe sufferers
The Latest on: Asthma pill
[google_news title=”” keyword=”Asthma pill” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Asthma pill
- Schools Aren't Prepared to Treat Asthma Attackson June 6, 2023 at 11:18 am
Currently, all 50 states have laws permitting students to self-carry and self-administer asthma medication in schools. However, as few as 14% of children have access to a personal inhaler while at ...
- Uncontrolled asthma a bigger risk for Black kidson June 5, 2023 at 12:55 am
Amid the balloons, cake and games at his best friend's birthday party on a farm, 5-year-old Carter Manson clutched his small chest.
- Black children are more likely to have asthma. A lot comes down to where they liveon June 4, 2023 at 3:51 am
Black children are more likely to have asthma than kids of any other race in America. They're more likely to live near polluting plants, and in rental housing with mold and other triggers, because of ...
- People With Asthma May Have a Higher Risk of Cancer—And Not Just Lung Canceron May 31, 2023 at 2:33 pm
assistant professor in the College of Medicine at the University of Florida and first author of the study, told Health. Guo and colleagues examined the potential association between asthma and ...
- People With Asthma May Have a Higher Risk of Cancer—And Not Just Lung Canceron May 31, 2023 at 2:33 pm
assistant professor in the College of Medicine at the University of Florida and first author of the study, told Health. Guo and colleagues examined the potential association between asthma and ...
- People With Asthma May Have a Higher Risk of Cancer—And Not Just Lung Canceron May 31, 2023 at 1:27 pm
A new study found that people with asthma may be 36% more likely to develop cancer than people without asthma. While a correlation is possible, both the research team and outside experts agree that ...
- Link confirmed: Infant RSV infections increase likelihood of childhood asthmaon May 29, 2023 at 9:17 pm
Research investigates the association between early-life respiratory syncytial virus (RSV) infection and the development of childhood asthma. It aims to assess the impact of RSV infection during ...
- Asthma: This new digital device helps monitor medication intakeon May 27, 2023 at 5:06 pm
Researchers say a digital device known as an Inhaler Compliance Assessment can help people with asthma improve their adherence to medication regiments ...
- If Asthma Runs in Your Family, Pay Attention to Your Sleepon May 25, 2023 at 6:55 am
Some people with a genetic predisposition to asthma might be more likely to get the condition if they have poor sleep habits. For people who have asthma, getting enough sleep might help them manage ...
- Black children are more likely to have asthma. A lot comes down to where they liveon May 24, 2023 at 12:19 pm
Asthma is treatable. It can be managed with medicine, routine appointments and inhalers. But Black children often struggle to get treatment, and are more likely than white kids to end up in the ...
via Bing News
